| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.52B | 131.89B | 128.00B | 111.80B | 116.28B | 105.06B |
| Gross Profit | 123.97B | 120.72B | 120.69B | 107.55B | 108.46B | 100.52B |
| EBITDA | 30.66B | 34.53B | 31.53B | 30.49B | 30.46B | 26.55B |
| Net Income | 20.62B | 20.84B | 19.32B | 18.63B | 17.19B | 14.72B |
Balance Sheet | ||||||
| Total Assets | 7.72T | 7.60T | 7.54T | 7.19T | 8.38T | 7.24T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.08T | 973.95B | 752.03B | 2.14T | 947.01B |
| Total Debt | 741.71B | 706.64B | 687.58B | 651.20B | 1.63T | 623.52B |
| Total Liabilities | 7.29T | 7.17T | 7.08T | 6.80T | 7.97T | 6.84T |
| Stockholders Equity | 430.79B | 419.13B | 446.67B | 388.72B | 398.90B | 389.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 0.00 | -1.37T | 0.00 | 19.28B |
| Operating Cash Flow | 0.00 | 0.00 | 0.00 | -1.37T | 0.00 | 21.26B |
| Investing Cash Flow | 0.00 | 107.83B | 70.66B | -8.18B | 82.70B | -422.14B |
| Financing Cash Flow | 0.00 | 97.55B | 115.21B | -5.92B | 131.60B | 706.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥367.64B | 7.80 | ― | 1.95% | 24.39% | 37.97% | |
76 Outperform | ¥376.00B | 9.60 | ― | 2.94% | 9.90% | 16.52% | |
71 Outperform | ¥381.87B | 6.86 | ― | 2.14% | 13.27% | 60.88% | |
68 Neutral | ¥472.68B | 11.65 | 3.95% | 2.19% | 12.38% | 17.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥444.40B | 14.75 | ― | 1.50% | 21.64% | 43.65% | |
55 Neutral | ¥229.50B | -94.53 | ― | 2.38% | 33.44% | 57.44% |